CANNAPHARMARX, INC. (CPMD) Return on equity 2019–2022
CANNAPHARMARX, INC. (CPMD) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-49.2%FY2022 · since FY2019: -421.3% → -49.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -49.2% | — |
| FY2019 | -421.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More CPMD financial trends
CPMD RevenueCPMD Net incomeCPMD Net marginCPMD Gross profitCPMD Gross marginCPMD Operating incomeCPMD Operating marginCPMD Operating cash flowCPMD Free cash flowCPMD Capital expendituresCPMD Stock buybacksCPMD Dividends paidCPMD Total assetsCPMD Total liabilitiesCPMD Shareholders’ equityCPMD overview →